Antidepressive therapy in depressed clinical suicides.

Area of Science:

• Psychiatry
• Clinical Psychology
• Neuroscience

Background:

• Suicide rates are increasing, particularly among individuals with depressive disorders.
• Current psychopharmacological treatment for depression may be inadequate.
• Diagnostic discrepancies can impact treatment effectiveness.

Purpose of the Study:

• To examine the psychopharmacological treatment received by individuals who died by suicide.
• To identify potential reasons for therapeutic inadequacy in depression treatment.
• To propose improvements in diagnostic and treatment practices to reduce suicide rates.

Main Methods:

• Analysis of 61 clinical suicide cases.
• Review of psychopharmacological treatments received at the time of suicide.
• Comparison of clinical diagnoses with Research Diagnostic Criteria (RDC) diagnoses.

Main Results:

• Less than half of the suicide cases received antidepressant treatment.
• Only a small minority of cases were optimally treated.
• A discrepancy between clinical and RDC diagnoses was noted as a factor in inadequate treatment.

Conclusions:

• Inadequate psychopharmacological treatment is prevalent in suicide cases with depressive disorders.
• Improving diagnostic accuracy, especially identifying depressive syndromes, is crucial.
• Enhanced diagnostic and treatment strategies may help lower the increasing suicide rate.